CARE Ratings Reaffirms ZIM Laboratories’ Ratings, Revises Long-Term Outlook to Negative
Zim Laboratories Ltd · Others (Uncategorized) · 09 Oct 2026, 1:50 am
CARE Ratings Reaffirms ZIM Laboratories’ Ratings, Revises Long-Term Outlook to Negative CARE Ratings reaffirmed ZIM Laboratories Limited’s credit ratings across its bank facilities while revising the outlook on long-term facilities to 'Negative' from 'Stable'. The company's long-term bank facilities totaling Rs 127.48 crore were reaffirmed at 'CARE BBB/Negative'. Additionally, short-term bank facilities amounting to Rs 12.00 crore were reaffirmed at 'CARE A3'. Total rated bank facilities stand at Rs 139.48 crore.
Original exchange filing (PDF)
More announcements from Zim Laboratories Ltd
- Transcript of Q2 & H1FY27 Earnings Conference Call · 12 Nov 2026
- Please find enclosed the disclosure pertaining to the audio recording of Q2 & H1 FY27 Earnings Conference Call. · 05 Nov 2026
- Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find enclosed the Earnings Presentation for Q2 & H1 FY27. · 05 Nov 2026
- Please find enclosed the financial results for the quarter and half year ended 30th September 2026 · 04 Nov 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today, .... · 04 Nov 2026
- Zim Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 04 Nov 2026
- We wish to inform you that Q2 & H1FY27 Earnings Conference Call is scheduled to be held on Thursday, 05th November, 2026 at 11:00 a.m. IST. · 31 Oct 2026
- ZIM Laboratories Limited has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 04 Nov 2026
